Attached files
| file | filename |
|---|---|
| EX-31.1 - EX-31.1 - Larimar Therapeutics, Inc. | d846636dex311.htm |
| EX-31.2 - EX-31.2 - Larimar Therapeutics, Inc. | d846636dex312.htm |
| EXCEL - IDEA: XBRL DOCUMENT - Larimar Therapeutics, Inc. | Financial_Report.xls |
| 10-K - FORM 10-K - Larimar Therapeutics, Inc. | d846636d10k.htm |
| EX-32.1 - EX-32.1 - Larimar Therapeutics, Inc. | d846636dex321.htm |
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-196900) of Zafgen, Inc. of our report dated March 24, 2015 relating to the consolidated financial statements, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
March 24, 2015